Company intelligence / Profile preview

Van Herk Biotech

Rotterdam, Netherlands

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Van Herk Biotech (Van Herk Biotech B.V.) is the life sciences investment arm of the Van Herk Groep, a private Dutch investment firm based in Rotterdam. Founded by billionaire Aat van Herk, the entity specializes in providing capital and strategic support to biotechnology and healthcare companies, primarily in the Benelux region. It has a notable track record of investing in high-profile European biotech firms such as Galapagos, Ablynx, Crucell, and argenx. The firm maintains a long-term investment perspective and is recognized as one of the most influential private investors in the Dutch life sciences ecosystem.

Industry: Investors

Beyond the preview

Go deeper on Van Herk Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Van Herk Biotech.

Explore the full profile